GUFICBIO / NSE / Biotechnology & Drugs
Gufic BioSciences
1Y Price Trend
Key Information
Recommendations
Target High409
Target Low267.5
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk35.56
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve Markets Mojo
Gufic BioSciences Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals Markets Mojo
Gufic Bio Consolidated March 2026 Net Sales at Rs 251.82 crore, up 22.83% Y-o-Y Moneycontrol.com
Gufic Biosciences Q1FY27 Concall: Margins, CapEx & Revenue Guidance scanx.trade
Gufic BioSciences Ltd Shows Mixed Technical Signals Amid Sideways Momentum Shift Markets Mojo
Gufic BioSciences Q4 FY26: Strong Profit Surge Masks Valuation Concerns Markets Mojo
Gufic BioSciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum Markets Mojo
GUFICBIO: Record Q4 results, margin expansion, and strong outlook with stable debt and no major CapEx TradingView
© SharekeyX | Rusaka Technologies 2024-2026

